DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study
about
DNA isolation method is a source of global DNA methylation variability measured with LUMA. Experimental analysis and a systematic reviewBlood-based DNA methylation as biomarker for breast cancer: a systematic reviewStorage conditions and stability of global DNA methylation in placental tissueIn utero exposures to environmental organic pollutants disrupt epigenetic marks linked to fetoplacental developmentDisagreement between two common biomarkers of global DNA methylationRelationships between Global DNA Methylation in Circulating White Blood Cells and Breast Cancer Risk Factors.Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women.LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participantsA BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.Methylome analysis and epigenetic changes associated with menarcheal ageDietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivorsGlobal DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women.Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.Transposable Elements in Human Cancer: Causes and Consequences of DeregulationSources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer.Genes with stable DNA methylation levels show higher evolutionary conservation than genes with fluctuant DNA methylation levelsPolycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based studymicroRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.Epigenome-wide association study of breast cancer using prospectively collected sister study samplesDNA methylation modifies the association between obesity and survival after breast cancer diagnosis.Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer.Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesityArsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylationGlobal DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.What's in a name? Context-dependent significance of 'global' methylation measures in human health and disease.Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Differences in DNA methylation by extent of breast cancer family history in unaffected womenDNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.Epigenetic reprogramming in breast cancer: from new targets to new therapies.DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers.DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patients.Correlation between global methylation level of peripheral blood leukocytes and serum C reactive protein level modified by MTHFR polymorphism: a cross-sectional study.Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral bloodEpigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancerAlu hypermethylation and high oxidative stress in patients with musculoskeletal tumors
P2860
Q26829876-725F1A3D-AF68-4DD3-B13A-3C419BB22668Q28072075-F69D9A7F-DAA5-45E2-B184-00FFD3F41A38Q28392514-73F299B8-2028-4C08-9C08-A0C4823BC710Q28396824-928B8ACE-62A7-44F2-AB62-714C115BD9E0Q28833594-4CDF9563-AA99-42E0-B660-612968D63CEBQ30234523-C2EB40E4-DA8B-48D4-82C7-46D89521F47CQ33682974-BA9164EB-966F-4211-B068-34A88E51D00FQ33740684-93BCC0EA-5191-46E4-8610-A54FFB435C53Q33948754-2C923AC3-312E-40D8-8124-311F98F903C3Q35053159-46256543-BE0D-4005-9497-5B5E35980C37Q35239448-07132269-3DE9-4831-BB0C-37D9D0492A85Q35631631-1D7AB8F3-60AF-4516-86D8-4A790EA9CC11Q36286909-B784075A-76CA-4C10-8734-6D38CE3B1C43Q36362814-3078C236-BB3D-4060-B659-3B21C8EDF3A0Q36445547-4FD448DE-5717-46E5-AF21-7C31D8E0BC3CQ36545588-AC24D5BF-BC68-4171-BBE7-DB1A0DC0B982Q36607318-3D1E58AE-D786-4A85-AE05-3029CF2A1C15Q36647044-A13A02B2-BE87-4E05-AD77-CAF316F3A8E8Q36843610-56B9A4A6-00CA-4431-A7FC-D781DC3BE7C0Q36961072-551F1849-1D8A-4E6D-AAB1-2F5F3CD78690Q37192664-CF7FA443-413D-429F-B678-E92A1CB9CFB7Q37379816-DFA0A9A4-96DA-4FA2-A874-3890D421DFD8Q37481330-1A3E3C35-341A-4FFC-AED4-B8ABD72B6362Q37537553-39049822-4C8E-4A7C-8528-F5E84045B164Q37609862-E13C4AA7-25A7-489C-B4D2-6AEEE893E314Q37639092-CD2A437A-E770-4398-B272-7CE729F9A571Q37655850-623CAD5D-8BD1-43DF-B9CD-8C03C91DB418Q37665624-B4DD3298-DBED-4520-AF33-61D38CFFEB81Q38233472-292B5A82-8930-4C33-9916-570807CDFC0CQ38528175-04D1876C-A523-4D0F-8F0B-974F468E7E71Q39132762-AD5CBD34-BC64-4EBB-A32D-C4812A9A8228Q40308621-73465887-805F-427A-B7CC-94F045CB50BAQ41461207-285A3909-B4D4-4945-84FF-7A40A1531F71Q47797107-D59A028C-8D16-4283-8E73-A5C758FE3AEAQ49199959-E928D535-CF7C-4B45-93A2-52BE9B650F25Q55007492-FC550FC6-3505-4347-99AF-B314C3DB9EC7Q55262096-CED70D90-8E77-42EE-9F9D-091EA84C7438Q57191514-66E2A3E3-3A6B-4FBA-902D-47F22EB3D9C1Q57265567-B6DB7B69-5682-4702-B6CD-50EEB1F2EED5Q58773784-B620CE8E-259F-4D19-99F6-BE4E2A7DEF82
P2860
DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
DNA methylation in peripheral ...... er in a population-based study
@ast
DNA methylation in peripheral ...... er in a population-based study
@en
type
label
DNA methylation in peripheral ...... er in a population-based study
@ast
DNA methylation in peripheral ...... er in a population-based study
@en
prefLabel
DNA methylation in peripheral ...... er in a population-based study
@ast
DNA methylation in peripheral ...... er in a population-based study
@en
P2093
P2860
P356
P1433
P1476
DNA methylation in peripheral ...... er in a population-based study
@en
P2093
Alfred I Neugut
Hector Hernandez-Vargas
James G Wetmur
Marilie D Gammon
Patrick T Bradshaw
Regina M Santella
Susan L Teitelbaum
Zdenko Herceg
P2860
P304
P356
10.1096/FJ.11-197251
P407
P50
P577
2012-02-27T00:00:00Z